National Institutes of Health: Support for Human Embryonic Stem Cell Research James F. Battey, Jr., MD, PhD.

Slides:

Advertisements

Similar presentations

Discovery: Stem Cell Biology NIH Actions Continue infrastructure award program Characterize cell lines Stimulate more research on basic biology Train.

Advertisements

NHLBI Strategic Visioning Process: Charting Our Future Together

What’s NIH? National Cancer Institute National Eye Institute National Heart, Lung, and Blood Inst. National Human Genome Research Inst National Institute.

“It is the responsibility of those of us involved in today’s biomedical research enterprise to translate the remarkable scientific innovations we are witnessing.

Karen H. Rothenberg, J.D., M.B.A. Dean and Marjorie Cook Professor of Law at the University of Maryland School of Law and Chair, Maryland Stem Cell Research.

Stem Cell Research at the NIH. What are the unique properties that make human embryonic stem cells (hESCs) special? hESCs have an unlimited capacity for.

1 NIH Clinical Center,CTSAs NIH Molecular Libraries Initiative Disease Target ID Assay Dev. HTS Probe to Lead Pre- Clinical FDA IND Ph. IPh. IIPh. III.

Technology Transfer: The NIH Experience Steven M. Ferguson, CLP Deputy Director, Licensing & Entrepreneurship Office of Technology.

NIH LOAN REPAYMENT PROGRAMS NIH Extramural Loan Repayment Programs An Overview: 2008 By Division of Loan Repayment Office of Extramural Research/Office.

Development of the International Stem Cell Registry: Progress and Challenges.

NIH Brown Bag Lunch SOT 2010 March 9, 2010 Janice Allen, PhD Michael Humble, PhD Division of Extramural Research and Training (DERT) National Institute.

IRB Monthly Investigator Meeting Columbia University Medical Center IRB October 11, 2005.

The NIH Roadmap for Medical Research

Department of Medicine Research Retreat 2/9/13 Breakout Session #4: Enhancing Industry-sponsored Research Opportunities Marco Costa, MD, PHD Neal Meropol,

Healthy Communities Access Program Public Health Institutes: A New Way of Doing Business May 20-21, 2004 Presented By Susan Lumsden Cephas Goldman, D.D.S.,

Stem Cells and Cancer Cancer Education Project University of Rochester.

Stem Cells General Concepts By Syed Tahir Abbas Shah.

Bill Newhouse Program Lead National Initiative for Cybersecurity Education Cybersecurity R&D Coordination National Institute of Standards and Technology.

Johns Hopkins Technology Transfer 1 Translational Biomedical Research: Moving Discovery from Academic Centers to the Community Translational Biomedical.

NIH Roadmap for Medical Research and Common Fund Update on Recent Changes Dinah Singer, Ph.D. Director, Division of Cancer Biology June 18, 2008.

The Immediate Challenge for NIH and Human ES Cell Research Generate and characterize distribution quality human ES cell lines from the NIH Registry Stimulate.

Dr Stewart Hay, CEO | | (03) www.therapeuticinnovation.com.au.

Stem Cells: Myths, Facts, and Ethics

Biotechnology Research Project by Anna Dong, Soojin Jeong, Reina Ooka -Stem Cells-

The University of North Carolina at Chapel Hill Mary H. Palmer, PhD, RN,C,FAAN Translational Research: Introduction.

NIH Investment in the Science of Learning Robert M. Kaplan NIH Associate Director for Behavioral and Social Sciences Sabrina Liao Geehta Senthil Office.

Dr. José M. Millán, PhD Deputy Director of CIBERER Universitary Hospital La Fe, Valencia, Spain Barriers and Challenges in Rare Diseases Research Centre.

The Ethics of Stem Cell Research Presented by Corey Gomes Bme 181 April 15, 2013.

The Review of Your NIH Grant Application Begins Here Richard Nakamura, Ph.D. Director NIH Center for Scientific Review.

The Role of Research in Osteopathic Medical Education American Association of Colleges of Osteopathic Medicine June 25, 2004 David B. Moore Associate Vice.

National Heart, Lung, and Blood Institute Cancer Research Opportunities Liana Harvath, NHLBI U.S. Department of Health and Human Services National Institutes.

American Evaluation Association EVALUATION 2009 November 14, 2009 Building Data Systems to Support Evaluation in a Biomedical Research and Development.

Investing in the State of Innovation International Seminar on Knowledge and Innovation 1 October, 2013 Creating a High-Performance Innovation Ecosystem:

Working Together to Work Wonders. The University of Texas Medical Branch Research: Advancing Knowledge, Improving Health David L. Callender, MD, MBA, FACS.

Ahsan Arsalan Stem Cells Present in almost all multi-cellular organisms No specialized functionality Can renew themselves Can differentiate into.

Registry Data Collection in Pediatric VADs: Challenges and Opportunities INTERMACS Eighth Annual Meeting May 5, 2014 David Rosenthal, MD Stanford Children’s.

Special NIH Funding Opportunities

BioEd Online Overview Mature tissue cell vs a stem cell What is a stem cell? How do we get stem cells? What is the difference between.

Expanding Biomedical Research in Maine Mount Desert Island Biological Laboratory Patricia H. Hand, Ph.D. Administrative Director.

Brought to you by the Letter “K” Donna L. Vogel, MD, PhD Director, Professional Development Office K Award Workshop December 11, 2007.

Susan R. Kayar, PhD Health Scientist Administrator Research Infrastructure NCRR, NIH Funding Opportunities through the National Center for Research Resources.

Discovery: Stem Cell Biology Proposed Actions Continue infrastructure award program Characterize cell lines Stimulate more research on basic biology Train.

Honors Biology CELL DIVISION & DIFFERENTIATION.  What are some reasons why cells divide?  Replacement  Growth  Regeneration  Too big (more on that.

UNDERSTANDING STEM CELLS By- Sayee Jadhav. Presentation Overview 2 1.What are stem cells? 2.What makes a cell a stem cell? 3.Types of stem cells 4.Stem.

Marguerite Littleton Kearney, PhD, RN, FAAN Director, Division of Extramural Science, NINR NIH/NINR Funding Opportunities in Family Health Research CANS.

President Obama Loosens Restrictions on Embryonic Stem Cell Research Rachel Kyllo 3/11/09 Sources: msnbc.com, startribune.com.

Team Building: Critical Role of Interdisciplinary Research Teams in Translational Research C. Kent Osborne, M.D. Director, Lester and Sue Smith Breast.

Delayed Onset Human Research formerly Limited Activities Determination (LAD) Karen Moe, Director Human Subjects Division.

Scientific Opportunities and Public Needs Resource Allocation and Priority Setting at the NIH.

STEM CELL RESEARCH MAKING THE SACRIFICE. THE HOPE CURE FOR IMPERVIOUS GENETIC DISEASE ALZHEIMER’S PARKINSON’S DIABETES REPAIR FOR INJURIES SPINAL CORD.

Why Write A Grant? Elaine M. Hylek, MD, MPH Professor of Medicine Associate Director, Education and Training Division BU CTSI Section of General Internal.

CBER Research: OBRR Office Site Visit Kathryn M. Carbone, MD Associate Director of Research CBER/FDA.

Future Directions for NIH Research in the Behavioral and Social Sciences Raynard S. Kington, MD, PhD Associate Director for Behavioral and Social Sciences.

Biomedical Research, Health Disparities and the Digital Divide: Programs at the NCRR Susan R. Kayar, Ph.D. Division of Research Infrastructure.

Personnel Director Curt R. Freed, M.D. Professor of Medicine and Pharmacology Professor of Medicine and Pharmacology Head, Div CP and Tox Head, Div CP.

IN THE NAME OF GOD. What are Stem Cells? Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types.

Science for Global Health: Fostering International Research Collaboration James Herrington, PhD, MPH Director Division of International Relations Fogarty.

Discovery: Stem Cell Biology NIH Actions Continue infrastructure award program Characterize cell lines Stimulate more research on basic biology Train.

What do we need to know to become stem cell literate?

Lessons Learnt The demise of thoracic surgery (Part II)

OUHSC Vision/Initiatives for

Stem Cells : Therapeutic Perspectives

Stem Cells PUPIL NOTES.

CSS Clinical Trial Launched: January 2018

cells  tissue  organs  organ systems  organism

Children’s Disability and Health Care Quality

Understanding the alphabet soup from funding agencies

Trial Funding and Engagement: The NIH Sponsored CTSA Program

Stem cell Basics.

THE TITLE OF MY TALK John Doe, M.D. Professor Department of Neurology

Presentation transcript:

National Institutes of Health: Support for Human Embryonic Stem Cell Research James F. Battey, Jr., MD, PhD

Speaker Disclosure The speaker has no relevant financial relationships to disclose.

Eligibility Criteria for Federal Funding

NIH Stem Cell Registry

Infrastructure Awards Awards to organizations with entries on NIH hESC Registry available for Federal funds to develop into distribution-quality cell lines Two year period of support Nine awards for total of over $6M Led to development of 22 hESC lines ready for shipment with more to come in near future

Stem Cell Training Short-term Courses in Human Embryonic Stem Cell Culture Techniques held at –The Jackson Laboratory –Univ. of Georgia –Univ. of Pittsburgh/Magee-Women’s Res. Inst. –Children’s Hospital of Orange County –Technion-Israel Institute Of Technology

NIH Intramural Research Several laboratories at NIH are currently using hESC in their research Expanding interest as cell line availability becomes more straightforward Creation of a stem cell characterization unit within Intramural Research Program at NIH

Centers of Excellence for Translational Stem Cell Research Multidisciplinary teams of stem cell experts, clinical researchers, and transplant surgeons Speed translation of basic knowledge to clinical therapies for human disease Test adult and embryonic stem cell therapies for many diseases including diabetes, heart disease, and neurological disorders

National Embryonic Stem Cell Bank Ready source of human embryonic stem cells (hESCs) Compare and expand hESCs available to NIH-supported scientists Ensure consistent hESC quality Reduce cost to obtain cells listed on the NIH Registry

NIH Supports Research on Many Types of Stem Cells Early phase of research—breakthroughs with clinical relevance might emerge from research on many types of stem cells FY2004 investment in human non- embryonic stem cell research--$203 million FY2004 investment in human embryonic stem cell research--$24.3 million Promote growth in both areas in the future

On the Research Horizon Definition of standardized human ES cell culture conditions that obviate the need for either mouse or human feeder cells Enabling tools and technologies to further characterize stem cells as they become specialized cells (specific antibodies, etc.) Define the molecular pathways that specify differentiation into different specialized cells

On the Research Horizon (cont.) Determine the factors/conditions critical for long-term survival and function of transplanted cells in a host Understand control of cell division— essential to expand cells before specialization, but must be tightly regulated after transplantation for therapy

NIH Stem Cell Website

NIH Stem Cell Website and Registry Stem Cell Information – Human Embryonic Stem Cell Registry –